Real-world experience with hypomethylating agents and venetoclax as induction or salvage therapy followed by allogeneic stem cell transplantation in patients with acute myeloid leukemia

被引：0

作者：

Rautenberg, C. ^{[1
]}

Stelljes, M. ^{[2
]}

Acker, F. ^{[3
]}

Holtick, U. ^{[4
]}

Jost, E. ^{[5
]}

Ragette, A. ^{[1
]}

Kaivers, J. ^{[1
]}

Tischer, J. ^{[6
]}

Fraccaroli, A. ^{[6
]}

Neuendor, N. ^{[1
]}

Hanoun, M. ^{[1
]}

Schmalbrock, L. K. ^{[7
]}

Braitsch, K. ^{[8
]}

Verbeek, M. ^{[8
]}

Goetze, K. ^{[8
]}

Bug, G. ^{[3
]}

Reinhardt, C. ^{[1
]}

Kroeger, N. ^{[9
]}

Schroeder, T. ^{[1
]}

机构：

[1] Uniklin Essen, Klin Hamatol & Stammzelltransplantat, Essen, Germany

[2] Uniklin Munster, Munster, Germany

[3] Uniklin Frankfurt, Frankfurt, Germany

[4] Uniklin Koln, Cologne, Germany

[5] Uniklin Aachen, Aachen, Germany

[6] LMU Munchen, Munich, Germany

[7] Charite Univ Med Berlin, Dept Hematol Oncol & Canc Immunol, Campus Benjamin Franklin, Berlin, Germany

[8] Klinikum Rechts Der Isar, Munich, Germany

[9] Uniklin Hamburg Eppendorf, Hamburg, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P369

引用

页码：193 / 193

页数：1